232 related articles for article (PubMed ID: 23732645)
1. Increased apical Na+ permeability in cystic fibrosis is supported by a quantitative model of epithelial ion transport.
O'Donoghue DL; Dua V; Moss GW; Vergani P
J Physiol; 2013 Aug; 591(15):3681-92. PubMed ID: 23732645
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid inhibits ENaC and Na/K pump activity to restore airway surface liquid height in cystic fibrosis bronchial epithelial cells.
Mroz MS; Harvey BJ
Steroids; 2019 Nov; 151():108461. PubMed ID: 31344409
[TBL] [Abstract][Full Text] [Related]
3. Effects of the serine/threonine kinase SGK1 on the epithelial Na(+) channel (ENaC) and CFTR: implications for cystic fibrosis.
Wagner CA; Ott M; Klingel K; Beck S; Melzig J; Friedrich B; Wild KN; Bröer S; Moschen I; Albers A; Waldegger S; Tümmler B; Egan ME; Geibel JP; Kandolf R; Lang F
Cell Physiol Biochem; 2001; 11(4):209-18. PubMed ID: 11509829
[TBL] [Abstract][Full Text] [Related]
4. Human cystic fibrosis airway epithelia have reduced Cl- conductance but not increased Na+ conductance.
Itani OA; Chen JH; Karp PH; Ernst S; Keshavjee S; Parekh K; Klesney-Tait J; Zabner J; Welsh MJ
Proc Natl Acad Sci U S A; 2011 Jun; 108(25):10260-5. PubMed ID: 21646513
[TBL] [Abstract][Full Text] [Related]
5. Low temperature and chemical rescue affect molecular proximity of DeltaF508-cystic fibrosis transmembrane conductance regulator (CFTR) and epithelial sodium channel (ENaC).
Qadri YJ; Cormet-Boyaka E; Rooj AK; Lee W; Parpura V; Fuller CM; Berdiev BK
J Biol Chem; 2012 May; 287(20):16781-90. PubMed ID: 22442149
[TBL] [Abstract][Full Text] [Related]
6. Epithelial sodium channel silencing as a strategy to correct the airway surface fluid deficit in cystic fibrosis.
Gianotti A; Melani R; Caci E; Sondo E; Ravazzolo R; Galietta LJ; Zegarra-Moran O
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):445-52. PubMed ID: 23600628
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide has no beneficial effects on ion transport defects in cystic fibrosis human nasal epithelium.
Rückes-Nilges C; Lindemann H; Klimek T; Glanz H; Weber WM
Pflugers Arch; 2000 Nov; 441(1):133-7. PubMed ID: 11205052
[TBL] [Abstract][Full Text] [Related]
8. New generation ENaC inhibitors detach cystic fibrosis airway mucus bundles via sodium/hydrogen exchanger inhibition.
Giorgetti M; Klymiuk N; Bähr A; Hemmerling M; Jinton L; Tarran R; Malmgren A; Åstrand A; Hansson GC; Ermund A
Eur J Pharmacol; 2021 Aug; 904():174123. PubMed ID: 33974881
[TBL] [Abstract][Full Text] [Related]
9. The effect of ambroxol on chloride transport, CFTR and ENaC in cystic fibrosis airway epithelial cells.
Varelogianni G; Hussain R; Strid H; Oliynyk I; Roomans GM; Johannesson M
Cell Biol Int; 2013 Nov; 37(11):1149-56. PubMed ID: 23765701
[TBL] [Abstract][Full Text] [Related]
10. The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis lung disease.
Moore PJ; Tarran R
Expert Opin Ther Targets; 2018 Aug; 22(8):687-701. PubMed ID: 30028216
[TBL] [Abstract][Full Text] [Related]
11. Lack of correlation between CFTR expression, CFTR Cl- currents, amiloride-sensitive Na+ conductance, and cystic fibrosis phenotype.
Beck S; Kühr J; Schütz VV; Seydewitz HH; Brandis M; Greger R; Kunzelmann K
Pediatr Pulmonol; 1999 Apr; 27(4):251-9. PubMed ID: 10230924
[TBL] [Abstract][Full Text] [Related]
12. Liquid movement across the surface epithelium of large airways.
Chambers LA; Rollins BM; Tarran R
Respir Physiol Neurobiol; 2007 Dec; 159(3):256-70. PubMed ID: 17692578
[TBL] [Abstract][Full Text] [Related]
13. Correlating genotype with phenotype using CFTR-mediated whole-cell Cl
Noel S; Servel N; Hatton A; Golec A; Rodrat M; Ng DRS; Li H; Pranke I; Hinzpeter A; Edelman A; Sheppard DN; Sermet-Gaudelus I
J Physiol; 2022 Mar; 600(6):1515-1531. PubMed ID: 34761808
[TBL] [Abstract][Full Text] [Related]
14. cAMP triggers Na
Luan X; Le Y; Jagadeeshan S; Murray B; Carmalt JL; Duke T; Beazley S; Fujiyama M; Swekla K; Gray B; Burmester M; Campanucci VA; Shipley A; Machen TE; Tam JS; Ianowski JP
Cell Rep; 2021 Oct; 37(1):109795. PubMed ID: 34610318
[TBL] [Abstract][Full Text] [Related]
15. The cystic fibrosis transmembrane conductance regulator impedes proteolytic stimulation of the epithelial Na+ channel.
Gentzsch M; Dang H; Dang Y; Garcia-Caballero A; Suchindran H; Boucher RC; Stutts MJ
J Biol Chem; 2010 Oct; 285(42):32227-32. PubMed ID: 20709758
[TBL] [Abstract][Full Text] [Related]
16. CFTR-mediated inhibition of epithelial Na+ conductance in human colon is defective in cystic fibrosis.
Mall M; Bleich M; Kuehr J; Brandis M; Greger R; Kunzelmann K
Am J Physiol; 1999 Sep; 277(3):G709-16. PubMed ID: 10484398
[TBL] [Abstract][Full Text] [Related]
17. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis.
Knowles MR; Paradiso AM; Boucher RC
Hum Gene Ther; 1995 Apr; 6(4):445-55. PubMed ID: 7542031
[TBL] [Abstract][Full Text] [Related]
18. SPX-101 Is a Novel Epithelial Sodium Channel-targeted Therapeutic for Cystic Fibrosis That Restores Mucus Transport.
Scott DW; Walker MP; Sesma J; Wu B; Stuhlmiller TJ; Sabater JR; Abraham WM; Crowder TM; Christensen DJ; Tarran R
Am J Respir Crit Care Med; 2017 Sep; 196(6):734-744. PubMed ID: 28481660
[TBL] [Abstract][Full Text] [Related]
19. Effects of rhinovirus infection on the expression and function of cystic fibrosis transmembrane conductance regulator and epithelial sodium channel in human nasal mucosa.
Kim JH; Kwon HJ; Jang YJ
Ann Allergy Asthma Immunol; 2012 Mar; 108(3):182-7. PubMed ID: 22374202
[TBL] [Abstract][Full Text] [Related]
20. The CFTR and ENaC debate: how important is ENaC in CF lung disease?
Collawn JF; Lazrak A; Bebok Z; Matalon S
Am J Physiol Lung Cell Mol Physiol; 2012 Jun; 302(11):L1141-6. PubMed ID: 22492740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
